| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 625850-78-4 | 3-(2-Ethyl-1,3-benzoxazol-7-yl)-1-propanamine | C12H16N2O |
| 625851-01-6 | [(1R,2R)-2-(2-Ethyl-1,3-benzoxazol-7-yl)cyclopropyl]methanol | C13H15NO2 |
| 625851-05-0 | (1R,2R)-2-(2-Ethyl-1,3-benzoxazol-7-yl)cyclopropanecarbaldehyde | C13H13NO2 |
| 625851-09-4 | 1-[(1R,2R)-2-(2-Ethyl-1,3-benzoxazol-7-yl)cyclopropyl]methanamine | C13H16N2O |
| 625851-44-7 | 4-Phenoxy-1,2-benzoquinone | C12H8O3 |
| 625852-10-0 | 3-[(1R)-1-Hydroxyethyl]phenol | C8H10O2 |
| 625852-58-6 | 6,7,8,8a-Tetrahydro-3(5H)-indolizinone | C8H11NO |
| 625853-72-7 | Hydroxy Pioglitazone (M-VII) | C19H20N2O4S |
| 625853-73-8 | Pioglitazone Sulfonic Acid | C18H22N2O5S |
| 625853-74-9 | 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-5-hydroxy-2,4-thiazolidinedione | C19H20N2O4S |
| 625853-75-0 | Hydroxy Pioglitazone (M-VII) beta-D-Glucuronide | C25H28N2O10S |
| 625853-76-1 | Hydroxy Pioglitazone (M-IV) beta-D-Glucuronide | C25H28N2O10S |
| 625854-02-6 | 9-(4-Bromophenyl)-10-phenyl-anthracene | C26H17Br |
| 625854-71-9 | L-Lysyl-L-isoleucyl-L-asparaginyl-L-lysyl-L-asparaginyl-L-prolyl-L-lysyl-L-tyrosyl-L-lysine | C52H89N15O13 |
| 626207-32-7 | Bromo(nonyl)zinc | C9H19BrZn |
| 626207-42-9 | Bromo(3-phenylpropyl)zinc | C9H11BrZn |
| 626210-44-4 | N-(2-Pyridinylmethyl)cyclopropanamine | C9H12N2 |
| 626210-49-9 | 1-(1,3-Benzodioxol-5-yl)-N-(2-pyridinylmethyl)methanamine | C14H14N2O2 |
| 626216-39-5 | N'-(2-Furylmethyl)-N,N-dimethyl-1,2-ethanediamine | C9H16N2O |
| 626217-76-3 | 4-Chloro-6-(1-pyrrolidinyl)-5-pyrimidinamine | C8H11ClN4 |
| 626217-79-6 | 1-Methyl-N-(3-pyridinylmethyl)-4-piperidinamine | C12H19N3 |
| 626217-94-5 | N,N'-Diethyl-N-(1-ethyl-4-piperidinyl)-1,2-ethanediamine | C13H29N3 |
| 626218-15-3 | N-(2-Fluorobenzyl)-2-propen-1-amine | C10H12FN |
| 626220-65-3 | 2-(4-Chlorobenzyl)-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)propanoic acid | C15H20ClNO4 |
| 626220-76-6 | (2R)-1-Methoxypropan-2-amine hydrochloride | C4H11NO.HCl |
| 626221-24-7 | 5-Hydroxy-2-(methylamino)-7-oxo-4,7-dihydrothieno[3,2-b]pyridine-3-carbonitrile | C9H7N3O2S |
| 626223-67-4 | 4-(Chloroacetyl)-3,3-dimethyl-2-piperazinone | C8H13ClN2O2 |
| 626223-93-6 | [2-(4-Ethyl-1-piperazinyl)-2-oxoethoxy]acetic acid | C10H18N2O4 |
| 626226-54-8 | 5-Hydroxy-2-(methylamino)[1,3]thiazolo[4,5-b]pyridin-7(4H)-one | C7H7N3O2S |
| 626227-15-4 | [(4,5-Dimethyl-4H-1,2,4-Triazol-3-Yl)Thio]-Acetonitrile | |
| 626231-70-7 | 2,3-Dihydrospiro[indene-1,2'-[1,3]oxathiolane] | C11H12OS |
| 626232-59-5 | 5-Methyl-3,4,5,6-tetrahydrocyclopenta[b]pyran-7(2H)-one | C9H12O2 |
| 626233-25-8 | 7-[(1E)-1-Ethoxy-1,3-butadien-1-yl]-4-ethyl-2,3,4,5-tetrahydrooxepine | C14H22O2 |
| 626234-67-1 | 5-Fluoro-2-phenyl-1,3-oxazole | C9H6FNO |
| 626238-08-2 | Methyl cis-3-hydroxy-1-methylcyclobutanecarboxylate | C7H12O3 |
| 626243-21-8 | Cyclohexyl (4R)-4-hydroxypentanoate | C11H20O3 |
| 626248-56-4 | 3-(2H-1,2,3-Triazol-2-yl)aniline | C8H8N4 |
| 626249-25-0 | (2R,6aR)-3-(Trimethylsilyl)-1,2,4,5,6,6a-hexahydro-2-pentalenol | C11H20OSi |
| 626250-54-2 | 3-Iodo-4-methylphenol | C7H7IO |
| 626252-87-7 | (1S,2S,3S)-3-Isopropyl-1,2-cyclohexanediol | C9H18O2 |
| 626255-73-0 | N-Methyl-N-[2-(methylamino)ethyl]propanamide | C7H16N2O |
| 626604-39-5 | GSK-3beta Inhibitor XI | C18H15N5O3 |
| 626604-79-3 | 2-(1-Ethyl-1H-pyrrolo[2,3-b]pyridin-3-yl)acetamide | C11H13N3O |
| 626604-80-6 | Ethyl oxo(1H-pyrrolo[2,3-b]pyridin-3-yl)acetate | C11H10N2O3 |
| 627034-85-9 | NF449 | C41H32N6Na8O29S8 |
| 627034-93-9 | Carbonic acid, 2-ethoxyethyl ethyl ester | C7H14O4 |
| 627060-91-7 | N-(2,6-Dimethylphenyl)-2,2,3,3-tetramethylcyclopropanecarboxamide | C16H23NO |
| 627061-11-4 | N-(2-Acetylphenyl)-2,2,3,3-tetramethylcyclopropanecarboxamide | C16H21NO2 |
| 627076-26-0 | (2,5-Difluorobenzyl)hydrazine | C7H8F2N2 |
| 627076-27-1 | [[2-(Trifluoromethyl)phenyl]methyl]hydrazine | C8H9F3N2 |